Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antithrombin III activity in subretinal fluid.

G Malukiewicz-Wiśniewska1, M Kotschy

  • 1Department of Ophthalmology, University School of Medical Sciences, Bydgoszcz, Poland.

European Journal of Ophthalmology
|November 9, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tissue factor, tissue factor pathway inhibitor and vascular endothelial growth factor-A in carotid atherosclerotic plaques.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2005
Same author

Selected haemostatic factors in carotid bifurcation plaques of patients undergoing carotid endarterectomy.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2004
Same author

[Endothelin in the plasma and cerebrospinal fluid of patients after head injury].

Neurologia i neurochirurgia polska·2002
Same author

[Von Willebrand factor in patients with subarachnoid hemorrhage].

Neurologia i neurochirurgia polska·2002
Same author

Long-term evaluation of endothelial cell loss after phacoemulsification.

European journal of ophthalmology·2002
Same author

Von Willebrand factor in subretinal fluid.

European journal of ophthalmology·2002
Same journal

Distinct interactions between macular neovascularization and geographic atrophy: Growth dynamics and fellow-eye risk.

European journal of ophthalmology·2026
Same journal

Association of spousal smoking exposure with epiretinal membrane in lifelong non-smoking women: A dyadic analysis of KNHANES 2019-2021.

European journal of ophthalmology·2026
Same journal

Long-term smoking and early-onset diabetic retinopathy in young-onset type 2 diabetes.

European journal of ophthalmology·2026
Same journal

Optimizing mitomycin C in photorefractive keratectomy: A paired-eye comparison of 15- versus 30-second applications.

European journal of ophthalmology·2026
Same journal

Honeycomb Keratopathy due to Rho-kinase inhibitor therapy.

European journal of ophthalmology·2026
Same journal

Mendelian randomisation in ophthalmology: An overview and practical guide for clinicians.

European journal of ophthalmology·2026
See all related articles

Antithrombin III (AT III) activity was detected in all subretinal fluid samples, though at significantly lower levels than in blood plasma. No correlation was found with patient or disease factors.

Area of Science:

  • Ophthalmology
  • Hematology
  • Biochemistry

Background:

  • Antithrombin III (AT III) is a key regulator of coagulation.
  • Understanding AT III levels in ocular fluids is crucial for retinal disease research.

Purpose of the Study:

  • To quantify antithrombin III (AT III) activity in subretinal fluid (SRF) and compare it with plasma levels.
  • To investigate potential correlations between SRF AT III activity and patient/disease characteristics.

Main Methods:

  • A prospective study involving 32 patients undergoing retinal detachment surgery.
  • Collection of subretinal fluid (SRF) and venous blood samples for AT III activity measurement.
  • Exclusion of patients with vascular diseases that could influence results.

Related Experiment Videos

Main Results:

  • Median AT III activity in SRF was 16.5%, significantly lower than the mean plasma level of 105%.
  • No significant correlation was observed between SRF AT III levels and age, sex, myopia, or retinal detachment parameters.
  • AT III activity was present in all analyzed SRF samples.

Conclusions:

  • Antithrombin III (AT III) is present in subretinal fluid (SRF) in patients with retinal detachment.
  • SRF AT III levels are substantially lower than plasma levels.
  • The role and origin of AT III in SRF warrant further investigation.